Author(s): Parameswari. P, Devika. R

Email(s): eshwari_2007@yahoo.com

DOI: 10.5958/0974-360X.2019.00919.3   

Address: Parameswari. P1*, Devika. R2
1Research Scholar, Department of Biotechnology, Sathyabama Institute of Science and Technology, Chennai-600119 Dist- Kancheepuram, India.
2Professor, Department of Biotechnology, Aarupadai Veedu Institute of Technology, Paiyanoor, Chennai-603104 Dist- Kancheepuram, India.
*Corresponding Author

Published In:   Volume - 12,      Issue - 11,     Year - 2019


ABSTRACT:
Quercetin (a plant flavonoid) having a spot with polyphenol extensively disseminated in nature. Quercetin has aglycone structure and other flavonoid glycosides are rutin and quercetin. The examination displayed the quercetin compound was the best compound exhibiting higher confining imperativeness. In the present examination quercetin was isolated from the leaf concentrate of Artemisia nilagirica (Clarke) Pamp and the concentrate was certified through various instrumental examinations. An undertaking has been made for docking study practices with the extraordinary perceived characteristics MSX 2, HOX A10, HOX A5 and MAPK 14 for quieting proteins and SGK-1, BAX, ZFN 26 and ADM for anticancer. The docking results showed that there exists a coupling relationship between each protein and the goal of ligand-protein docking is to anticipate the overwhelming confining models of a ligand with a protein of known three dimensional structures. Docking considers yielded basic information concerning the presentation of the inhibitors in the coupling pocket of the objective proteins. The present work recognizes the potential remedy that concentrations against the receptor proteins as a characteristic solution to cure inflammation and cancer. The examination reveals that Quercetin can go utilized as medication to fix irritation and dangerous development. Fundamental point of this examination is to limit the dangerous impact of open medications to the common human cell. The examination displayed the Quercetin compound was the best compound appearing limiting imperativeness when differentiated Quercetin and moderating protein MAPK14 receptor leaving - 9.7 kcal/mol and anticancer proteins SGK-1 receptor is - 9.5 kcal/mol of confining essentialness. Taken together our results show that Quercetin may go about as alleviating and anticancer compound by affecting the NF-?B pathway. Further examinations in pre-clinical and clinical examinations are justified to illuminate the helpful capability of Quercetin for clinical use.


Cite this article:
Parameswari. P, Devika. R. In silico Molecular Docking Studies of Quercetin Compound against Anti-inflammatory and Anticancer Proteins. Research J. Pharm. and Tech. 2019; 12(11):5305-5309. doi: 10.5958/0974-360X.2019.00919.3

Cite(Electronic):
Parameswari. P, Devika. R. In silico Molecular Docking Studies of Quercetin Compound against Anti-inflammatory and Anticancer Proteins. Research J. Pharm. and Tech. 2019; 12(11):5305-5309. doi: 10.5958/0974-360X.2019.00919.3   Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-11-31


Recomonded Articles:

Author(s): Vishal Vilas Shah, Nutan Dhanpal Shah, Prasad Vasantrao Patrekar

DOI: Not Available         Access: Open Access Read More

Author(s): Ahmed Hilal Sheriff, Preetham Prasad Nittla

DOI: 10.5958/0974-360X.2019.00968.5         Access: Open Access Read More

Author(s): Justin Antony, Satadal Debroy, Chennu Manisha, Peet Thomas, Victoria Jeyarani, Tenzin Choephel

DOI: 10.5958/0974-360X.2019.00367.6         Access: Open Access Read More

Author(s): Sonte Sushmitha, Sedimbi Revathi Priyanka, L. Mohan Krishna, M. Srinavasa Murthy

DOI: Not Available         Access: Open Access Read More

Author(s): Mythili. L, GNK. Ganesh, C. Monisha, Kayalvizhi. R

DOI: 10.5958/0974-360X.2019.00426.8         Access: Open Access Read More

Author(s): Suchithra. A. B, S. Jeganath, E. Jeevitha

DOI: 10.5958/0974-360X.2019.01073.4         Access: Open Access Read More

Author(s): Vaseeha Banu T.S., Sandhya K.V., K.N. Jayaveera

DOI: Not Available         Access: Open Access Read More

Author(s): Vandana Gautam, Dhriti Kapoor, Saroj Arora, Renu Bhardwaj*

DOI: 10.5958/0974-360X.2016.00166.9         Access: Open Access Read More

Author(s): Siripurapu Sriram, Venkata Ravibabu Mandla, Chaithanya Sudha M, Saladi S.V. Subba Rao, Nagaveni Ch, Vani V., Gobinath P., Raj Kumar KVG., Jaydeep Lella, Sannidhi Krishna Praveen, Debjit Datta

DOI: 10.5958/0974-360X.2017.00078.6         Access: Open Access Read More

Author(s): Archana Kushwaha, Jayanti Jaiswal, Priya Singh, Neha Rathore, Jai Prakash Dhruw, Ishu Sahu, Chhaya Singh, Krinsha Kumar Sahu, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00270.0         Access: Open Access Read More

Author(s): Amutha K*, Ashok Kumar A, Godavari A

DOI: 10.5958/0974-360X.2017.00100.7         Access: Open Access Read More

Author(s): Moghal. Roohi Shabreen, S. Sangeetha

DOI: 10.5958/0974-360X.2020.00355.8         Access: Open Access Read More

Author(s): Sindhu Priya. S, B. Ramamurthy

DOI: 10.5958/0974-360X.2018.00379.7         Access: Open Access Read More

Author(s): Priti Patel, Ashok Kumar P., Hemil Shah, Nikunj Patel, Pratik Kheni, Someshwara Rao B., Suresh V. Kulkarni, Babitha S.

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags